1887

Abstract

Four T cell determinants in the major capsid protein of human papillomavirus (HPV) type 16 LI and one in the E6 protein associated with cellular transformation were defined using synthetic peptides to stimulate peripheral blood mononuclear cells from asymptomatic individuals. HLA-DR restriction was defined using murine L cells transfected with HLA-DR genes to present antigen. Responses to two of the five determinants by T cell lines and clones were shown to be specific for HPV-16 based on the lack of crossrecognition of the corresponding sequences of other known papillomavirus sequences (types la, 5,6b, 8,11, 18 and 33). The T cells raised against two of the other peptides cross-reacted with corresponding peptides from other strains to varying extents, depending on their structural homology. The implications of these results regarding the prevalence of HPV-16 infection in the population and the possible diagnostic role of these responses in papillomavirus infection is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-2-423
1990-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/2/JV0710020423.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-2-423&mimeType=html&fmt=ahah

References

  1. Barany G., Merrifield R. 1979; Solid phase peptide synthesis. In The Peptides pp. 1–284 Gross E., Meienhofer J. Edited by New York: Academic Press;
    [Google Scholar]
  2. Cole S. T., Danos O. 1987; Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Journal of Molecular Biology 193:599–608
    [Google Scholar]
  3. Cole S. T., Streeck R. E. 1986; Genome organisation and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. Journal of Virology 58:991
    [Google Scholar]
  4. Cubie H. A., Norval M. 1988; Humoral and cellular immunity to papillomavirus in patients with cervical dysplasia. Journal of Medical Virology 24:85–95
    [Google Scholar]
  5. Danos O., Katinka M., Yaniv M. 1982; Human papillomavirus la complete DNA sequence: a novel type of genome organisation among Papovaviridae. EMBO Journal 1:231–236
    [Google Scholar]
  6. Dartmann K., Schwarz E., Gissman N. L., Zur Hausen H. 1986; The nucleotide sequence and genome organisation of human papillomavirus type 11. Virology 151:124–130
    [Google Scholar]
  7. Fuchs P. G., Iftner T., Weninger J., Pfister H. 1986; Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. Journal of Virology 58:626–634
    [Google Scholar]
  8. Gelb L. 1985; Varicella-zoster virus. In Virology pp. 591–627 Fields B. N. Edited by New York: Raven Press;
    [Google Scholar]
  9. Good M. F., Quakyi J. A., Saul A., Berzofsky J. A., Carter R., Miller L. H. 1987; Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete- reactive T cells in peripheral blood from nonexposed donors. Journal of Immunology 138:306–311
    [Google Scholar]
  10. Guttinger M., Caspers P., Takacs B., Trzeciak A., Gillessen D., Pink J. R., Sinigaglia F. 1988; Human T cells recognise polymorphic and non-polymorphic regions of the Plasmodium falciparum circumsporozoite protein. EMBO Journal 7:2555–2558
    [Google Scholar]
  11. Ikeda H., Trowsdale J., Saito I. 1988; Mulcos: a vector for amplification and simultaneous expression of two foreign genes in mammalian cells. Gene 71:19–27
    [Google Scholar]
  12. Jablonsky S., Orth G., Croissant O., Obalek S. 1985; The clinical morphology, pathology and immunology of papillomavirus infections of the skin as related to the virus type. In Papillomaviruses: Molecular and Clinical Aspects pp. 69–83 Howley P. M., Broker T. R. Edited by New York: Alan R. Liss;
    [Google Scholar]
  13. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. A. 1988; Identification of immunoreactive antigens of human papillomavirus type 6b using Escherichia coli-expressed fusion proteins. Journal of Virology 623:2115–2123
    [Google Scholar]
  14. Kirchner H. 1986; Immunobiology of human papillomavirus infection. Progress in Medical Virology 33:1–41
    [Google Scholar]
  15. Lamb J., Eckels D., Phelan M., Laka P., Woody J. 1982; Antigen specific T cell clones; viral antigen specificity of influenza virus immune clones. Journal of Immunology 128:1428–1434
    [Google Scholar]
  16. Lock C. B., So A. K. L., Welsh K. J., Parkes J. D., Trowsdale J. 1988; MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 27:449–455
    [Google Scholar]
  17. Morison W. L. 1975; Viral warts, herpes simplex and herpes zoster in patients with secondary immunodeficiencies and neoplasms. British Journal of Dermatology 92:625
    [Google Scholar]
  18. Pfister H. 1987; Human papillomaviruses and genital cancer. Advances in Cancer Research 48:113–147
    [Google Scholar]
  19. Porreco R., Penn I., Droegemueller W., Greer B., Makowski E. 1975; Gynecologic malignancies in immunosup-pressed organ homograft recipients. Journal of Obstetrics and Gynecology 45:359–367
    [Google Scholar]
  20. Reddehase M. J., Rothbard J. R., Koszinowski U. 1989; A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651–653
    [Google Scholar]
  21. Rickinson A. B., Yao Q. Y., Wallace L. E. 1985; The Epstein- Barr virus as a model of virus-host interactions. British Medical Bulletin 41:75–79
    [Google Scholar]
  22. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 1:93–100
    [Google Scholar]
  23. Schwarz E., Dürst M., Demankowski C., Latterman O., Zech R., Wolfsperger E., Suhai S., Zur Hausen H. 1983; DNA sequence and genome organisation of human papillomavirus type 6b. EMBO Journal 2:2341–2348
    [Google Scholar]
  24. Seedorf K., Krammer G., Dürst M., Suhai S., Rowekamp W. G. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
  25. Siliciano R. F., Lawton T., Knall C., Karr R. W., Berman P., Gregory T., Reinherz E. L. 1988; Analysis of host-virus interactions in AIDS with anti-gp 120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 54:561–575
    [Google Scholar]
  26. Sissons J. G. P., Borysiewicz L. K., Rodgers B., Scott D. 1986; Cytomegalovirus - its cellular immunology and biology. Immunology Today 7:57–61
    [Google Scholar]
  27. Storey A., Pim D., Murray A., Osborn K., Banks L., Crawford L. 1988; Comparison of the in vitro transforming activities of human papillomavirus types. EMBO Journal 7:1815–1820
    [Google Scholar]
  28. Townsend A. R. M., Rothbard J. B., Gotch F. M., Bahadur G., Wraith D., Mcmichael A. J. 1986; The epitopes of influenza nucleoprotein recognised by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959–968
    [Google Scholar]
  29. Wildy P., Gell P. G. H. 1985; The host response to herpes simplex virus. British Medical Bulletin 41:86–91
    [Google Scholar]
  30. Young J. A. T., Wilkinson D., Bodmer W. F., Trowsdale J. 1987; Sequence and evolution of HLA-DR7 and -w53 associated β- chain genes. Proceedings of the National Academy of Sciences, U.S.A 84:4929–4933
    [Google Scholar]
  31. Young L. S., Bevan I. S., Johnson M. A., Blomfield P. I., Brombridge T., Maitland N. J., Woodman C. B. J. 1989 British Medical Journal 298:14–18
    [Google Scholar]
  32. Zachow K. R., Ostrow R. S., Faras A. J. 1987; Nucleotide sequence and genome organisation of human papillomavirus type 5. Virology 158:251–254
    [Google Scholar]
  33. Zuckerman A. J., Howard C. R. 1979; . In Hepatitis Viruses of Man pp. 114–129 New York & London: Academic Press;
    [Google Scholar]
  34. Zur Hausen H., Schneider A. 1987; The role of papillomaviruses in human anogenital cancer. In The Papovaviridae: The Papilloma-viruses pp. 245–263 Howley P. M., Salzman N. Edited by New York: Plenum Press;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-2-423
Loading
/content/journal/jgv/10.1099/0022-1317-71-2-423
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error